(Press-News.org) New research in mice reveals why the body is so slow to recover from jet-lag and identifies a target for the development of drugs that could help us to adjust faster to changes in time zone.
With funding from the Wellcome Trust and F. Hoffmann La Roche, researchers at the University of Oxford and F. Hoffmann La Roche have identified a mechanism that limits the ability of the body clock to adjust to changes in patterns of light and dark. And the team show that if you block the activity of this gene in mice, they recover faster from disturbances in their daily light/dark cycle that were designed to simulate jet-lag.
Nearly all life on Earth has an internal circadian body clock that keeps us ticking on a 24-hour cycle, synchronising a variety of bodily functions such as sleeping and eating with the cycle of light and dark in a solar day. When we travel to a different time zone our body clock eventually adjusts to the local time. However this can take up to one day for every hour the clock is shifted, resulting in several days of fatigue and discombobulation.
In mammals, the circadian clock is controlled by an area of the brain called the suprachiasmatic nuclei (SCN) which pulls every cell in the body into the same biological rhythm. It receives information from a specialised system in the eyes, separate from the mechanisms we use to 'see', which senses the time of day by detecting environmental light, synchronising the clock to local time. Until now, little was known about the molecular mechanisms of how light affects activity in the SCN to 'tune' the clock and why it takes so long to adjust when the light cycle changes.
To investigate this, the Oxford University team led by Dr Stuart Peirson and Professor Russell Foster, used mice to examine the patterns of gene expression in the SCN following a pulse of light during the hours of darkness. They identified around 100 genes that were switched on in response to light, revealing a sequence of events that act to retune the circadian clock. Amongst these, they identified one molecule, SIK1, that terminates this response, acting as a brake to limit the effects of light on the clock. When they blocked the activity of SIK1, the mice adjusted faster to changes in light cycle.
Dr Peirson explains: "We've identified a system that actively prevents the body clock from re-adjusting. If you think about, it makes sense to have a buffering mechanism in place to provide some stability to the clock. The clock needs to be sure that it is getting a reliable signal, and if the signal occurs at the same time over several days it probably has biological relevance. But it is this same buffering mechanism that slows down our ability to adjust to a new time zone and causes jet lag."
Disruptions in the circadian system have been linked to chronic diseases including cancer, diabetes, and heart disease, as well as weakened immunity to infections and impaired cognition. More recently, researchers are uncovering that circadian disturbances are a common feature of several mental illnesses, including schizophrenia and bipolar disorder.
Russell Foster, Director of the recently established Oxford University Sleep and Circadian Neuroscience Institute supported by the Wellcome Trust, said: "We're still several years away from a cure for jet-lag but understanding the mechanisms that generate and regulate our circadian clock gives us targets to develop drugs to help bring our bodies in tune with the solar cycle. Such drugs could potentially have broader therapeutic value for people with mental health issues."
The findings were published online today in the journal Cell.
### END
Study reveals why the body clock is slow to adjust to time changes
2013-08-29
ELSE PRESS RELEASES FROM THIS DATE:
Feinstein Institute researchers track Huntington's disease progression using PET scans
2013-08-29
MANHASSET, NY – Investigators at The Feinstein Institute for Medical Research have discovered a new way to measure the progression of Huntington's disease, using positron emission tomography (PET) to scan the brains of carriers of the gene. The findings are published in the September issue of The Journal of Clinical Investigation.
Huntington's disease causes the progressive breakdown of nerve cells in the brain, which leads to impairments in movement, thinking and emotions. Most people with Huntington's disease develop signs and symptoms in their 40s or 50s, but the onset ...
Bad to the bone: some breast cancer cells are primed to thrive
2013-08-29
When a cancer cell sloughs off the edge of a tumor in the breast, it faces a tough road to survive. The cell must not only remain physically intact as it rushes through blood vessels, but it also must find a new organ to lodge itself in, take in enough nutrients and oxygen to stay alive, and begin dividing, all while escaping notice by the body's immune system.
A team of Howard Hughes Medical Institute (HHMI) scientists has discovered that some loose breast cancer cells, have a leg up on survival—the genes they express make them more likely to prosper in bone tissue. ...
Scientists map molecular mechanism that may cause toxic protein buildup in dementing disorders
2013-08-29
SAN FRANCISCO, CA—August 29, 2013—There is no easy way to study diseases of the brain. Extracting brain cells, or neurons, from a living patient is difficult and risky, while examining a patient's brain post-mortem usually only reveals the disease's final stages. And animal models, while incredibly informative, have frequently fallen short during the crucial drug-development stage of research. But scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF) have taken a potentially more powerful approach: an advanced stem-cell technique ...
CRISPR/Cas genome engineering system generates valuable conditional mouse models
2013-08-29
CAMBRIDGE, Mass. (August 29, 2013) – Whitehead Institute researchers have used the gene regulation system CRISPR/Cas to engineer mouse genomes containing reporter and conditional alleles in one step. Animals containing such sophisticated engineered alleles can now be made in a matter of weeks rather than years and could be used to model diseases and study gene function.
"We've used CRISPR/Cas to mutate genes before, but the nature of the targeted mutations has been unpredictable," says Whitehead Founding Member Rudolf Jaenisch. "Now we can make specific deletions defined ...
Pre-pregnancy hormone testing may indicate gestational diabetes risk
2013-08-29
OAKLAND, Calif., August 29, 2013 — Overweight women with low levels of the hormone adiponectin prior to pregnancy are nearly seven times more likely to develop gestational diabetes, according to a Kaiser Permanente study published today in the journal Diabetes Care. Adiponectin protects against insulin resistance, inflammation and heart disease.
Using Kaiser Permanente HealthConnect®, an electronic health records system, the researchers retrospectively identified about 4,000 women who gave voluntary blood samples between 1985 and 1996 during routine care and subsequently ...
Digesting milk in Ethiopia: A case of multiple genetic adaptations
2013-08-29
A genetic phenomenon that allows for the selection of multiple genetic mutations that all lead to a similar outcome -- for instance the ability to digest milk -- has been characterised for the first time in humans.
The phenomenon, known as a 'soft selective sweep', was described in the population of Ethiopia and reveals that individuals from the Eastern African population have adapted to be able to digest milk, but via different mutations in their genetic material.
A team of geneticists from UCL, University of Addis Ababa and Roskilde University have shown that five ...
Human heart disease recently found in chimpanzees
2013-08-29
Los Angeles -- While in the past century there have been several documented examples of young, healthy athletes who have died suddenly of heart disease during competitive sporting events, a new study finds that this problem also extends to chimpanzees. According to an article published today in the SAGE journal Veterinary Pathology, Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), a human heart disease that causes sudden cardiac death in teenagers and young adults (particularly healthy athletes), has now been identified in chimpanzees.
"It is the first description ...
Learning how the brain takes out its trash may help decode neurological diseases
2013-08-29
ANN ARBOR—Imagine that garbage haulers don't exist. Slowly, the trash accumulates in our offices, our homes, it clogs the streets and damages our cars, causes illness and renders normal life impossible.
Garbage in the brain, in the form of dead cells, must also be removed before it accumulates, because it can cause both rare and common neurological diseases, such as Parkinson's. Now, University of Michigan researchers are a leap closer to decoding the critical process of how the brain clears dead cells, said Haoxing Xu, associate professor in the U-M Department of Molecular, ...
New PRA gene identified in Phalenes and Papillons
2013-08-29
Professor Hannes Lohi's research group at the University of Helsinki and Folkhälsan Research Center, Finland, has identified a mutation in CNGB1 gene, causing progressive retinal atrophy (PRA) in the Phalene and Papillon dog breeds. PRA is one of the most common causes of blindness in dogs and in human. CNGB1 mutations have been previously associated with the corresponding human disease, human retinitis pigmentosa. This study highlights the shared genetic etiology of many canine and human genetic disorders, and provides new tools to investigate PRA mechanisms while the ...
More efficient production of biofuels from waste with the help of modified yeasts
2013-08-29
A significant portion of the petroleum consumed by the transport sector must be replaced in the long term by renewable energy. Therefore, it is of the utmost economic and ecological importance to optimise the production of biofuels from renewable raw materials. Researchers from VIB who are associated with KU Leuven have developed yeast strains that produce bio-ethanol from waste with an unprecedented efficiency. As a result, they are well placed to become important players on a global scale in this burgeoning industry.
Johan Thevelein (VIB/KU Leuven): "Our new yeast strains ...